JP2002501379A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501379A5
JP2002501379A5 JP1998544308A JP54430898A JP2002501379A5 JP 2002501379 A5 JP2002501379 A5 JP 2002501379A5 JP 1998544308 A JP1998544308 A JP 1998544308A JP 54430898 A JP54430898 A JP 54430898A JP 2002501379 A5 JP2002501379 A5 JP 2002501379A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998544308A
Other languages
English (en)
Other versions
JP2002501379A (ja
JP4907751B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/007723 external-priority patent/WO1998046722A1/en
Publication of JP2002501379A publication Critical patent/JP2002501379A/ja
Publication of JP2002501379A5 publication Critical patent/JP2002501379A5/ja
Application granted granted Critical
Publication of JP4907751B2 publication Critical patent/JP4907751B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2002501379
Figure 2002501379
Figure 2002501379
Figure 2002501379
JP54430898A 1997-04-16 1998-04-15 培地へのペプチドの直接発現 Expired - Lifetime JP4907751B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4370097P 1997-04-16 1997-04-16
US60/043,700 1997-04-16
PCT/US1998/007723 WO1998046722A1 (en) 1997-04-16 1998-04-15 Direct expression of peptides into culture media

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011245398A Division JP5634971B2 (ja) 1997-04-16 2011-11-09 培地へのペプチドの直接発現

Publications (3)

Publication Number Publication Date
JP2002501379A JP2002501379A (ja) 2002-01-15
JP2002501379A5 true JP2002501379A5 (ja) 2005-11-10
JP4907751B2 JP4907751B2 (ja) 2012-04-04

Family

ID=21928441

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54430898A Expired - Lifetime JP4907751B2 (ja) 1997-04-16 1998-04-15 培地へのペプチドの直接発現
JP2011245398A Expired - Lifetime JP5634971B2 (ja) 1997-04-16 2011-11-09 培地へのペプチドの直接発現

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011245398A Expired - Lifetime JP5634971B2 (ja) 1997-04-16 2011-11-09 培地へのペプチドの直接発現

Country Status (14)

Country Link
US (5) US6103495A (ja)
EP (2) EP2088188B1 (ja)
JP (2) JP4907751B2 (ja)
AT (2) ATE484572T1 (ja)
AU (1) AU742270B2 (ja)
CA (1) CA2285658C (ja)
DE (1) DE69841939D1 (ja)
DK (2) DK2088188T3 (ja)
ES (1) ES2375330T3 (ja)
HU (1) HUP0001272A3 (ja)
LT (1) LT4701B (ja)
NO (1) NO327325B1 (ja)
RU (1) RU2218407C2 (ja)
WO (1) WO1998046722A1 (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE484572T1 (de) * 1997-04-16 2010-10-15 Unigene Lab Inc Direkte expression von peptiden ins kulturmedium
KR100385298B1 (ko) * 2000-09-05 2003-05-23 한국생명공학연구원 단백질 생산방법
US7166575B2 (en) * 2002-12-17 2007-01-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
TW200411053A (en) 2002-12-30 2004-07-01 Ind Tech Res Inst Nucleic acid encoding recombinant salmon calcitionin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
EP1758927A4 (en) * 2004-01-21 2008-09-17 Unigene Lab Inc PARATHYROID HORMONE AMIDE FRAGMENTS AND USES THEREOF
US8227241B2 (en) * 2004-03-12 2012-07-24 Unigene Laboratories, Inc. Bacterial host cell for the direct expression of peptides
US7531518B2 (en) * 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7648965B2 (en) 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060089723A1 (en) * 2004-10-25 2006-04-27 Murphy Kieran P Method for bone augmentation
US7445911B2 (en) * 2004-11-24 2008-11-04 Unigene Laboratories Inc. Enzymatic reactions in the presence of keto acids
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US20060293667A1 (en) * 2005-05-19 2006-12-28 Agnes Vignery Bone implant device and methods of using same
WO2006130806A2 (en) * 2005-06-01 2006-12-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Assay for agonists and antagonists of ion channels and for regulators of genetic expression
WO2006132925A2 (en) 2005-06-01 2006-12-14 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
CA2613471C (en) 2005-06-24 2016-09-06 Unigene Laboratories, Inc. Cell lines for expressing enzyme useful in the preparation of amidated products
CA2658654A1 (en) 2006-07-24 2008-01-31 Biorexis Pharmaceutical Corporation Exendin fusion proteins
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
RU2370280C2 (ru) * 2007-10-08 2009-10-20 Институт физико-химической биологии им. А.Н.Белозерского СПОСОБ СУПЕРПРОДУКЦИИ В РАСТЕНИИ АНТИТЕЛ ПРОТИВ ОНКОГЕНА HER2/neu
US9422559B2 (en) 2010-06-02 2016-08-23 Shi-Lung Lin Production and utilization of a novel anti-cancer drug in therapy
US9399773B2 (en) 2012-08-10 2016-07-26 Shi-Lung Lin Production and extraction of MicroRNA precursor as drug for cancer therapy
CN102292346B (zh) 2009-01-22 2015-12-02 关键生物科学有限公司 肥胖的治疗
US9102753B2 (en) 2011-06-15 2015-08-11 Ugp Therapeutics, Inc. Anti-inflammatory pharmaceutical products
JP6185468B2 (ja) * 2011-08-12 2017-08-23 メロ バイオテクノロジー インコーポレイテッドMello Biotechnology,Inc. 原核細胞内においてヘアピン様rnaを発現させる方法及び組成物
EP3095484B1 (en) 2011-11-02 2018-05-02 KeyBioscience AG Calcitonin mimetics for treating diseases and disorders
AU2012332265B2 (en) 2011-11-02 2016-11-10 Keybioscience Ag Peptide analogs for treating diseases and disorders
US9102751B2 (en) * 2012-05-18 2015-08-11 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
US10414808B2 (en) 2012-05-18 2019-09-17 Janssen Biotech, Inc. Huwentoxin-IV variants and methods of use
US10196662B2 (en) 2012-08-10 2019-02-05 Mello Biotechnology, Inc. Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors
JP6375314B2 (ja) 2013-03-05 2018-08-15 エンテリス・バイオファーマ・インコーポレイテッドEnteris Biopharma,Inc. 固体経口投与剤
KR20160064192A (ko) 2013-10-03 2016-06-07 얀센 바이오테크 인코포레이티드 프로톡신-ii 변이체 및 사용 방법
EP3321278B1 (en) 2013-11-14 2019-01-09 KeyBioscience AG Calcitonin mimetics for treating diseases and disorders
CN103709236B (zh) * 2013-12-23 2015-04-15 江南大学 一种可提高分泌效率的信号肽及其应用
US9833411B2 (en) 2015-01-12 2017-12-05 Enteris Biopharma, Inc. Solid oral dosage forms
MA41642A (fr) 2015-03-03 2018-01-09 Janssen Biotech Inc Variants de protoxine ii et méthodes d'utilisation
EP3277304B1 (en) 2015-04-02 2021-08-04 Janssen Biotech, Inc. Protoxin-ii variants and methods of use
WO2017095489A1 (en) 2015-12-02 2017-06-08 Shi-Lung Lin Use of microrna precursors as drugs for inducing cd34-positive adult stem cell expansion
WO2017095458A1 (en) 2015-12-02 2017-06-08 Chih-Li Lin A COMPOSITION AND METHOD OF USING miR-302 PRECURSORS AS DRUGS FOR TREATING ALZHEIMER'S DISEASES
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB202001024D0 (en) 2020-01-24 2020-03-11 Key Bioscience Ag Oxyntomodulin mimetics

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332664A (en) * 1981-07-15 1994-07-26 Celltech Limited Human calcitonin precursor polyprotein structural gene
US4595658A (en) 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4962055A (en) * 1983-03-08 1990-10-09 Rikagaku Kenkyusho Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
US4708934A (en) * 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
US6319685B1 (en) * 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
US5747281A (en) * 1984-09-28 1998-05-05 Cornell Research Foundation, Inc. System useful for the production of proteins from recombinant DNA in single celled organisms
DE3586386T2 (de) * 1984-10-05 1993-01-14 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
DE3632037A1 (de) 1986-09-20 1988-04-07 Hoechst Ag Gentechnisches verfahren zur herstellung von salm-calcitonin sowie mittel zur durchfuehrung dieses verfahrens
US5089406A (en) * 1987-01-07 1992-02-18 Allied-Signal Inc. Method of producing a gene cassette coding for polypeptides with repeating amino acid sequences
US4946790A (en) * 1987-02-06 1990-08-07 Mitsui Toatsu Chemicals, Inc. Recombinant plasmid for the expression of L-phenylalanine ammonia-lyase and transformed strain carrying same
US5789234A (en) * 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US5223407A (en) 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JP2551399B2 (ja) * 1989-08-15 1996-11-06 株式会社資生堂 C末端アミド化に関与する酵素並びにその製造方法及びその使用
US5240831A (en) * 1991-01-10 1993-08-31 Board Of Regents, The University Of Texas Methods and compositions for the expression of biologically active eukaryotic cytochrome p45os in bacteria
US5547862A (en) * 1993-07-29 1996-08-20 Ambion Inc. Vectors containing multiple promoters in the same orientation
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
ATE484572T1 (de) * 1997-04-16 2010-10-15 Unigene Lab Inc Direkte expression von peptiden ins kulturmedium

Similar Documents

Publication Publication Date Title
JP2000509912A5 (ja)
JP2000510751A5 (ja)
JP2000509637A5 (ja)
JP2000509942A5 (ja)
JP2000507042A5 (ja)
JP2000509635A5 (ja)
JP2000507433A5 (ja)
JP2000507369A5 (ja)
JP2000509587A5 (ja)
JP2000510793A5 (ja)
JP2000508866A5 (ja)
JP2000508022A5 (ja)
JP2000511460A5 (ja)
JP2000508841A5 (ja)
JP2001509360A5 (ja)
JP2000508680A5 (ja)
JP2000509804A5 (ja)
JP2000509853A5 (ja)
JP2001512443A5 (ja)
JP2000510969A5 (ja)
JP2000509755A5 (ja)
JP2000508836A5 (ja)
JP2000509818A5 (ja)
JP2000509520A5 (ja)
JP2000510247A5 (ja)